Johnson & Johnson CEO Rules Out Obesity Market Entry, Focuses on Cancer and AI
Joaquin Duato states the firm prioritizes oncology and dementia research while noting artificial intelligence's potential to accelerate drug discovery.
Headline and summary written by an AI model from the linked article; not reviewed by a person. How this was made
This story has stopped developing; this page is its permanent record. More from that day
The odds
Each tick is a source publishing on this story
Price data
| Time | Chance of yes |
|---|---|
| now | 18% |
| 13 Oct, 14:42 UTC | 13% |
| 13 Oct, 14:13 UTC | 15% |
| 13 Oct, 13:50 UTC | 9% |
| 13 Oct, 13:25 UTC | 16% |
| 13 Oct, 12:58 UTC | 52% |
| 13 Oct, 12:15 UTC | 30% |
| 13 Oct, 11:41 UTC | 64% |
| 13 Oct, 11:27 UTC | 50% |
| 13 Oct, 10:44 UTC | 53% |
| 13 Oct, 10:01 UTC | 51% |
| 13 Oct, 09:33 UTC | 57% |
| 13 Oct, 08:40 UTC | 63% |
| 13 Oct, 07:42 UTC | 66% |
| 13 Oct, 06:08 UTC | 69% |
| 13 Oct, 05:22 UTC | 65% |
| 13 Oct, 04:34 UTC | 69% |
| 13 Oct, 04:15 UTC | 72% |
| 13 Oct, 02:20 UTC | 61% |
| 13 Oct, 01:14 UTC | 61% |
| 13 Oct, 00:35 UTC | 62% |
| 12 Oct, 22:27 UTC | 58% |
| 12 Oct, 21:19 UTC | 65% |
| 12 Oct, 18:47 UTC | 60% |
| 12 Oct, 17:49 UTC | 58% |
| 12 Oct, 15:40 UTC | 64% |
| 12 Oct, 13:55 UTC | 59% |
| 12 Oct, 13:29 UTC | 58% |
| 12 Oct, 12:56 UTC | 61% |
| 12 Oct, 12:11 UTC | 60% |
| 12 Oct, 11:32 UTC | 62% |
| 12 Oct, 07:28 UTC | 64% |
| 12 Oct, 05:37 UTC | 65% |
| 12 Oct, 04:54 UTC | 57% |
| 12 Oct, 04:10 UTC | 67% |
| 12 Oct, 03:25 UTC | 54% |
| 12 Oct, 02:28 UTC | 55% |
| 12 Oct, 01:50 UTC | 56% |
| 12 Oct, 01:00 UTC | 55% |
| 12 Oct, 00:41 UTC | 49% |
| 12 Oct, 00:15 UTC | 58% |
| 11 Oct, 22:02 UTC | 47% |
| 11 Oct, 21:19 UTC | 48% |
| 11 Oct, 20:47 UTC | 49% |
| 11 Oct, 19:52 UTC | 45% |
| 11 Oct, 19:24 UTC | 44% |
| 11 Oct, 16:32 UTC | 49% |
| 11 Oct, 14:42 UTC | 48% |
| 11 Oct, 14:02 UTC | 49% |
| 11 Oct, 13:51 UTC | 51% |
| 11 Oct, 12:39 UTC | 50% |
| 11 Oct, 12:14 UTC | 51% |
| 11 Oct, 06:37 UTC | 47% |
| 11 Oct, 03:32 UTC | 50% |
| 10 Oct, 22:07 UTC | 51% |
| 10 Oct, 20:41 UTC | 50% |
| 10 Oct, 18:46 UTC | 51% |
| 10 Oct, 17:21 UTC | 45% |
| 10 Oct, 14:27 UTC | 49% |
| 10 Oct, 11:04 UTC | 48% |
| 10 Oct, 09:08 UTC | 44% |
| 9 Oct, 23:32 UTC | 50% |
| 9 Oct, 19:37 UTC | 49% |
| 9 Oct, 18:28 UTC | 48% |
| 9 Oct, 14:31 UTC | 51% |
| 9 Oct, 03:40 UTC | 49% |
| 9 Oct, 01:42 UTC | 50% |
| 9 Oct, 00:03 UTC | 48% |
| 8 Oct, 23:10 UTC | 47% |
| 8 Oct, 18:46 UTC | 52% |
| 8 Oct, 17:16 UTC | 49% |
| 8 Oct, 14:44 UTC | 47% |
| 7 Oct, 13:26 UTC | 54% |
The story so far
1 publisher has covered this in 1 article since 8 Oct 2026. Bloomberg Markets published first, on 8 October at 14:25 UTC.
One prediction market prices this story:
- AI / Artificial Intelligence — resolved “No” on 13 Oct 2026. The market resolves to Yes if any Johnson & Johnson representative mentions AI or artificial intelligence during the upcoming earnings call, including the question-and-answer session. It resolves to No if no such mention occurs. Readers often mistakenly believe that general discussions about technology or innovation count as AI references, but only explicit mentions of "AI" or "artificial intelligence" qualify.
Odds are the market's probability that the outcome happens, updated every few minutes. They are information about what traders expect, not a forecast we make and not investment advice.
Sources
Every article we clustered into this story. Headlines link to the publisher.
Related prediction markets
Linked by software because they are about the same subject. Most ask a different question from the one this story reports, so read each market's own question. How often the link is right
- Resolved AI / Artificial Intelligence No 25d ago
The market favoured Yes at 59% a day out, but No won. How often it's right
Wrong market?
In this story
- Joaquin Duato
- Johnson & Johnson